-
Belec L, Cancre N, Hallouin M C. High prevalence in Central Africa of blood donors who are potentially infectious for human herpesvirus 8[J]. Transfu-sion, 1998, 38(8): 771-775. doi: 10.1046/j.1537-2995.1998.38898375517.x
-
Cesarman E, Chang Y, Moore P S. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas[J]. N Engl J Med, 1995, 332(18): 1186-1191. doi: 10.1056/NEJM199505043321802
-
Chang Y, Cesarman E, Pessin M S. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma[J]. Science, 1994, 266(5192): 1865-1869. doi: 10.1126/science.7997879
-
Engels E A, Sinclair M D, Biggar R J. Latent class analysis of human herpesvirus 8 assay performance and infection prevalence in sub-saharan Africa and Malta[J]. Int J Cancer, 2000, 88(6): 1003-1008. doi: 10.1002/(ISSN)1097-0215
-
Engels E A, Whitby D, Goebel P B. Identifying human herpesvirus 8 infection: performance characteristics of serologic assays[J]. J Acquir Immune Defic Syndr, 2000, 23(4): 346-354. doi: 10.1097/00042560-200004010-00011
-
Fujii T, Taguchi H, Katano H. Seropreva-lence of human herpesvirus 8 in human immuno-deficiency virus 1-positive and human immunodeficiency virus 1-negative populations in Japan[J]. J Med Virol, 1999, 57(2): 159-162. doi: 10.1002/(ISSN)1096-9071
-
Lin S F, Sun R, Heston L. Identification, expression, and immunogenicity of Kaposi's sarcoma-associated herpesvirus-encoded small viral capsid antigen[J]. J Virol, 1997, 71(4): 3069-3076.
-
Melbye M, Cook P M, Hjalgrim H. Risk factors for Kaposi's-sarcoma-associated herpesvirus (KSHV/ HHV-8) seropositivity in a cohort of homosexual men, 1981-1996[J]. Int J Cancer, 1998, 77(4): 543-548. doi: 10.1002/(ISSN)1097-0215
-
Russo J J, Bohenzky R A, Chien M C. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)[J]. Proc Natl Acad Sci USA, 1996, 93(25): 14862-14867. doi: 10.1073/pnas.93.25.14862
-
Schulz T F. Kaposi's sarcoma-associated herpes-virus (human herpesvirus-8)[J]. J Gen Virol, 1998, 79(Pt 7): 1573-1591.
-
Simpson G R, Schulz T F, Whitby D. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen[J]. Lancet, 1996, 348(9035): 1133-1138. doi: 10.1016/S0140-6736(96)07560-5
-
Wang L. Pathogenesis and associated Diseases of Kaposi's Sarcoma-associated Herpesvirus[J]. Virol Sin, 2007, 22(3): 248-255. doi: 10.1007/s12250-007-0029-9
-
Whitby D, Luppi M, Barozzi P. Human herpesvirus 8 seroprevalence in blood donors and lym-phoma patients from different regions of Italy[J]. J Natl Cancer, 1998, Inst90(5): 395-397.
-
Zeng Y, Zhang X, Huang Z. Intracellular Tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi's sarcoma-associated herpes-virus: role of JAK/STAT signaling[J]. J Virol, 2007, 81(5): 2401-2417. doi: 10.1128/JVI.02024-06